Compare
AsiaStrategy vs One & one Green Technologies. Inc vs Greenlane Holdings, Inc. vs Bio Green Med Solution, Inc.
| Latest fiscal year | AsiaStrategy SORARevenue covers only part of its income (partial revenue) | One & one Green Technologies. Inc YDDL | Greenlane Holdings, Inc. GNLN | Bio Green Med Solution, Inc. BGMS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $65.82M | $4.36M | $747.0K |
| Revenue growth (YoY) | n/a | +23.1% | -67.2% | n/m |
| Gross margin | n/a | 23.9% | -286.2% | n/a |
| Operating margin | n/a | 18.0% | n/m | n/m |
| Net margin | n/a | 17.9% | n/m | -401.3% |
| Net income | $12.29M | $11.81M | -$85.58M | -$3.00M |
| EPS (Diluted) | $0.50 | $0.23 | -$11.42 | -$6.45 |
| Operating cash flow | -$4.32M | -$9.73M | -$16.26M | -$4.77M |
| Free cash flow | -$4.33M | -$9.76M | -$16.36M | n/a |
| Cash & equivalents | $1.46M | $957.3K | $32.51M | $3.50M |
| Total assets | $39.72M | $56.04M | $74.93M | $8.19M |
| Total liabilities | $17.92M | $14.22M | $7.21M | $1.34M |
| Shareholders' equity | $21.80M | $41.82M | $67.87M | $6.84M |
| Return on year-end equity | 56.4% | 28.2% | -126.1% | -43.8% |
| Shares outstanding | 24.86M | n/a | n/a | 5.40M |
Revenue, most recent five fiscal years
| Fiscal year | AsiaStrategy | One & one Green Technologies. Inc | Greenlane Holdings, Inc. | Bio Green Med Solution, Inc. |
|---|---|---|---|---|
| Latest | n/a | $65.82M Ended 2025-12-31 | $4.36M Ended 2025-12-31 | $747.0K Ended 2025-12-31 |
| 1 year earlier | n/a | $53.46M Ended 2024-12-31 | $13.28M Ended 2024-12-31 | $43.0K Ended 2024-12-31 |
| 2 years earlier | n/a | $41.27M Ended 2023-12-31 | $65.37M Ended 2023-12-31 | $420.0K Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $137.09M Ended 2022-12-31 | $0 Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $166.06M Ended 2021-12-31 | $0 Ended 2021-12-31 |